Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups

Clinical Chemistry

Volumn 42, Issue 3, 1996, Pages 373-379

  Datta, Pradip ^a   Xu, Lei ^b   Malik, Sohail ^b,c   Landicho, Del ^b   Ferreri, Laurance ^d   Halverson, Kevin ^b   Roby, Paul V ^b   Zebelman, Arthur M ^e   Kenny, Margaret A ^b  

^a Ciba Corning Diagnostics Corporation   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Northwest Clinical Laboratories   (United States)

^e Laboratory of Pathology   (United States)

Author keywords

digoxin like immunoreactive factors; drug metabolism; drug monitoring; methods comparison

Indexed keywords

DIGITOXIN; DIGOXIN; DIGOXIN ANTIBODY;

ANTIBODY SPECIFICITY; ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIGOXIN BLOOD LEVEL; HUMAN; IMMUNOASSAY;

EID: 0029937715     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.3.373     Document Type: Article

References (24)

1. Lewis RP. Clinical use of serum digoxin concentrations. Am J Cardiol 1992;39:767-75.
2. Cook JD, Koch TR, Cook MS, Knoblock EC. Inaccuracies in digoxin measurement. Clin Biochem 1988;21:353-7.
3. Karbowki JA, Godley PJ, Frohna PA, Horton MW, Reitmeyer WJ. Marked digoxin-like immunoreactive factor interference with an enzyme immunoassay. Drug Intell Clin Pharm 1988;22:703-4.
4. Thong B, Soldin SJ, Lingwood CA. Lack of specificity of current anti-digoxin antibodies, and preparation of a new, specific, polyclonal antibody that recognizes the carbohydrate moiety of digoxin. Clin Chem 1985;31:1625-31.
5. Soldin SJ. Digoxin - issues and controversies [Review]. Clin Chem 1986;32:5-12.
6. Pudek MR, Seccombe DW, Humphries K. Digoxin-like immunoreactive substances and bile acids in the serum of patients with liver disease [Letter]. Clin Chem 1986;32:2005-6.
7. Dasgupta A, Saldana S, Heimann P. Monitoring free digoxin instead of total digoxin in patients with congestive heart failure and high concentrations of digoxin-like immunoreactive substances. Clin Chem 1990;36:2121-3.
8. Iosefsohn M, Soldin SJ, Hicks JM. A dry-strip immunometric assay for digoxin on the Ames Seralyzer. Ther Drug Monit 1990;12: 201-5.
9. Valdes R Jr. Endogenous digoxin-like immunoreactive factors: impact on digoxin measurements and potential physiological implications [Review]. Clin Chem 1985;31:1525-32.
10. Shaikh IM, Lau BW, Siegfried BA, Valdes R Jr. Isolation of digoxin-like immunoreactive factors from mammalian adrenal cortex. J Biol Chem 1991;266: 13672-8.
11. Schoner W. Endogenous digitalis-like factors. Clin Exp Hypertens A 1992;14:767-814.
12. Tymiak AA, Norman JA, Bolgar M, DiDonato GC, Lee H, Parker WL, et al. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci U S A 1993;90:8189-93.
13. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, et al. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A 1991;88:6259-63.
14. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.
15. Clerico A, Balzan S, Del CMG, Paci A, Cocci F, Bertelli A. Endogenous cardiac glycoside-like substances in newborns, adults, pregnant women and patients with hypertension or renal insufficiency. Drugs Exp Clin Res 1988;14:603-7.
16. Kerkez SA, Poston L, Wolfe CD, Quartero HW, Carabelli P, Petruckevitch A, et al. A longitudinal study of maternal digoxin-like immunoreactive substances in normotensive pregnancy and pregnancy-induced hypertension. Am J Obstet Gynecol 1990;162: 783-7.
17. Naomi S, Graves S, Lazarus M, Williams GH, Hollenberg NK. Variation in apparent serum digitalis-like factor levels with different digoxin antibodies. Am J Hypertens 1991;4:795-801.
18. Schlebusch H, Jarausch J, Domke I. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay. Wien Klin Wochenschr Suppl 1992;191:59-66.
19. Kenny MA, Ahmad S, Malik S. Novel steroid glycosides useful as hypertensives and in the early detection of hypertension and in other assays and therapy. US Appl 520,175 (1990), PCT 1991.
20. Goto A, Yamada K, Yagi N, Hui C, Terano Y, Sugimoto T. Ouabain as endogenous digitalis-like factor in animals [Letter]? Clin Chem 1992;38:161-2.
21. Valdes R Jr, Graves SW. Protein binding of endogenous digoxin like immunoreactive factor in human serum and its variation with clinical condition. J Clin Endocrinol Metab 1985;60:1135-43.
22. Avendano C, Alvarez JS, Sacristan JA, Adin J, Alsar MJ. Interference of digoxin-like immunoreactive substances with TDx Digoxin II assay in different patients. Ther Drug Monit 1991;13:523-7.
23. Miller JJ, Straub RW, Valdes R Jr. Digoxin immunoassay with cross-reactivity of digoxin metabolites proportional to their biological activity. Clin Chem 1994;40:1898-903.
24. Datta P, Larsen F. Specificity of digoxin immunoassays toward digoxin metabolites [Letter]. Clin Chem 1994;40:1348-9.